Prospective clinical trial of hepatitis B vaccination for children with hematological malignancies: a study on the safety and immunogenicity efficacy

References

• Su H, Shao Z, Pu Z, Wang Y, Zhang L, Zhang W, Wang B, Wang A, Ji Z, Yan Y, et al. Overt and occult hepatitis B virus infection among community children in Northwest China. J Viral Hepat. 2017;24(9):797–803. doi:10.1111/jvh.12709.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang F, Zhang Z. Current advances in the elimination of hepatitis B in China by 2030. Front Med. 2017;11(4):490–501. doi:10.1007/s11684-017-0598-4.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27(47):6550–57. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Cui J, Cao L, Zheng JS, Cao LS, Yuan P, Li L. Coverage analysis of national immunization program vaccines reported in China,2013. Chin J Vacc Imm. 2015;21(3):289–94. doi:CNKI:SUN:ZGJM..
   Google Scholar
• Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer. 1992;69(6):1481–86. doi:10.1002/1097-0142(19920315)69:6<481::aid-cncr2820690628>3.0.co;2-l.
   PubMed Web of Science ®Google Scholar
• Kovacs GT, Barany O, Schlick B, Csoka M, Gado J, Ponyi A, Müller J, Nemeth J, Hauser P, Erdelyi DJ, et al. Late immune recovery in children treated for malignant diseases. Pathol Oncol Res. 2008;14(4):391–97. doi:10.1007/s12253-008-9073-5.
   PubMed Web of Science ®Google Scholar
• Esposito S, Cecinati V, Brescia L, Principi N. Vaccinations in children with cancer. Vaccine. 2010;28(19):3278–84. doi:10.1016/j.vaccine.2010.02.096.
   PubMed Web of Science ®Google Scholar
• Moser M, Leo O. Key concepts in immunology. Vaccine 2010;28(Suppl 3):C2–13. doi:10.1016/j.vaccine.2010.07.022.
   PubMedGoogle Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–62. doi:10.1002/hep.23190.
   PubMed Web of Science ®Google Scholar
• Shouval D, Shibolet O. Immunosuppression and HBV reactivation. Semin Liver Dis. 2013;33(2):167–77. doi:10.1055/s-0033-1345722.
   PubMed Web of Science ®Google Scholar
• Perrillo RP, Martin P, Lok AS. Preventing hepatitis B reactivation due to immunosuppressive drug treatments. JAMA. 2015;313(16):1617–18. doi:10.1001/jama.2015.2571.
   PubMed Web of Science ®Google Scholar
• Ozkurt ZN, Suyani E, Haznedar R, Yağcı M. A randomized study comparing the efficacy of three hepatitis B vaccine induction regimens in adult patients with hematological malignancies. Turk J Haematol. 2016;33(3):231–35. doi:10.4274/tjh.2015.0079.
   PubMed Web of Science ®Google Scholar
• Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, et al. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4(5):e202–e217. doi:10.1016/S2352-3026(17)30052-2.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Xu N, Huang C, Li X, Li J. High risk of occult hepatitis B virus infection in leukemia patients from China. Arch Virol. 2017;162(2):349–57. doi:10.1007/s00705-016-3111-5.
   PubMed Web of Science ®Google Scholar
• Akimkin VG, Ledin EV, Skvortsov SV, Rukavitsyn OA. Incidence of hepatitis B virus infection in patients with blood disease. Ter Arkh. 2007;79(11):28–31.
   Web of Science ®Google Scholar
• Kibria CH, Islam KA, Islam MA, Rahman A, Biswash AK. Hepatitis B antibody level falls after initial phage of chemotherapy in childhood haematological malignancy. Mymensingh Med J. 2019;28(2):418–22.
   PubMedGoogle Scholar
• Ghosh N, Mannan MA, Monjur F, Rizwan F, Salim AF. Escalated regimen of hepatitis B vaccine in childhood hematological malignancies while on chemotherapy. Southeast Asian J Trop Med Public Health. 2010;41(3):555–61.
   PubMed Web of Science ®Google Scholar
• Elkady A, Aboulfotuh S, Ali EM, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Lijima S, Tanaka Y. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol. 2013;19(37):6214–20. doi:10.3748/wjg.v19.i37.6214.
   PubMed Web of Science ®Google Scholar
• Inoue T, Tanaka Y. Cross-protection of hepatitis B vaccination among different genotypes. Vaccines (Basel). 2020 Aug 16;8(3). doi:10.3390/vaccines8030456.
   PubMed Web of Science ®Google Scholar
• Keskin YZ, Buyukavci M. Assessment of humoral immunity to hepatitis B, measles, rubella, and mumps in children after chemotherapy. J Pediatr Hematol Oncol. 2018;40(2):e99–e102. doi:10.1097/mph.0000000000001072.
   PubMed Web of Science ®Google Scholar
• Conrad A, Alcazer V, Valour F, Ader F. Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible? Expert Rev Vaccines. 2018;17(4):299–309. doi:10.1080/14760584.2018.1449649.
   PubMed Web of Science ®Google Scholar
• Xiang G, Chou Jing XS. Application of expert consensus to guide the vaccination of children with special health status. Chin J Prevent Med. 2021;55(2):284–87. doi:10.3760/cma.j.cn112150-20201013-01275.
   Google Scholar
• YI W. Expert consensus on immunization in children with special health state (ⅩⅩIII) ——Allo-HSCT and immunization. Chin J Pract Pediatr. 2019;34(7):538–40. doi:10.19538/j.ek2019070602.
   Google Scholar
• Fayea NY, Kandil SM, Boujettif K, Fouda AE. Assessment of hepatitis B virus antibody titers in childhood cancer survivors. Eur J Pediatr. 2017;176(9):1269–73. doi:10.1007/s00431-017-2970-4.
   PubMed Web of Science ®Google Scholar
• Mormile R. Hepatitis B vaccine non response: a predictor of latent autoimmunity? Med Hypotheses. 2017 Jul;104:45–47. doi:10.1016/j.mehy.2017.05.020.
   PubMed Web of Science ®Google Scholar
• Viana SS, Araujo GS, Faro GB, Cruz-Silva LLD, Araújo-Melo CA, Cipolotti R. Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia. Rev Bras Hematol Hemoter. 2012;34(4):275–79. doi:10.5581/1516-8484.20120071.
   PubMedGoogle Scholar
• Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatr Infect Dis J. 2007;26(11):1038–41. doi:10.1097/inf.0b013e3181342887.
   PubMed Web of Science ®Google Scholar
• Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185–93. doi:10.1016/j.ijsu.2020.04.018.
   PubMed Web of Science ®Google Scholar
• Peng F, Tu L, Yang Y, Hu P, Wang R, Hu Q, Cao F, Jiang T, Sun J, Xu G, et al. Management and Treatment of COVID-19: the Chinese Experience. Can J Cardiol. 2020;36(6):915–30. doi:10.1016/j.cjca.2020.04.010.
   PubMed Web of Science ®Google Scholar